Cellular Dynamics International, which develops and manufactures functioning human cells in large quantities, raised $46 million by offering 3.8 million shares at $12, the low end of the range of $12 to $14. Cellular Dynamics International plans to list on the NASDAQ under the symbol ICEL. J.P. Morgan acted as bookrunner on the deal.
